Clinical trials
Anemia, Sickle Cell trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Terminated | 17 |
| Recruiting | 10 |
| Unknown status | 7 |
| Active, not recruiting | 6 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 8 |
| Novartis Pharmaceuticals | 6 |
| AstraZeneca | 4 |
| Agios Pharmaceuticals, Inc. | 3 |
| CSL Behring | 3 |
| Forma Therapeutics, Inc. | 3 |
| King's College London | 3 |
| Novo Nordisk A/S | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| ApoPharma | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 76 |
| Hemoglobinopathies | 11 |
| Thalassemia | 9 |
| Vaso-Occlusive Crises | 9 |
| Anemia | 7 |
| Hematologic Diseases | 7 |
| Anemia, Diamond-Blackfan | 4 |
| Genetic Diseases, Inborn | 4 |
| Pain | 4 |
| Sickle Cell Trait | 4 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.